Laboratorios SALVAT SA:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Laboratorios SALVAT SA - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C2803
◆発行会社(調査会社):GlobalData
◆発行日:2018年8月
◆ページ数:20
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:スペイン
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Laboratorios SALVAT SA (SALVAT) is a pharmaceutical company with focus on the development and commercialization of innovative medicines. The company manufactures drugs in various segments such as personal healthcare, digestive / metabolism, urological conditions, ophthalmological diseases, ENT, dermatology and malaria. It also offers antiseptics, nutraceuticals and probiotics. SALVAT’s R&D efforts extend to ENT and ophthalmology, dermatology and gastroenterology. It established SALVAT Biotech to pursue advancements in molecular diagnosis, regenerative medicine and new forms of drug delivery. The company has operations with a commercial office in the US, and markets its products through a network of distributors across Europe, America, Asia and Africa, and the Middle East. SALVAT is headquartered in Barcelona, Spain.

Laboratorios SALVAT SA – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Laboratorios SALVAT SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Laboratorios SALVAT SA, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Laboratorios SALVAT SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Laboratorios SALVAT SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Laboratorios SALVAT SA, Medical Devices Deals, 2012 to YTD 2018 9
Laboratorios SALVAT SA, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Laboratorios SALVAT SA, Pharmaceuticals & Healthcare, Deal Details 11
Licensing Agreements 11
iCo Therapeutics Enters into Licensing Agreement with Laboratorios SALVAT 11
Laboratorios SALVAT Enters into Licensing Agreement with Lee’s Pharma 12
Laboratorios SALVAT Enters into Licensing Agreement with Pediapharm 13
Laboratorios SALVAT Enters Into Licensing Agreement With FAES Farma 14
Equity Offering 15
Loop Therapeutics Spin Off from Laboratorios SALVAT 15
Laboratorios SALVAT SA – Key Competitors 16
Laboratorios SALVAT SA – Key Employees 17
Laboratorios SALVAT SA – Locations And Subsidiaries 18
Head Office 18
Other Locations & Subsidiaries 18
Recent Developments 19
Product News 19
05/18/2017: Pediapharm Announces the Commercial Launch of Otixal in Canada 19
Appendix 20
Methodology 20
About GlobalData 20
Contact Us 20
Disclaimer 20

List of Tables
Laboratorios SALVAT SA, Pharmaceuticals & Healthcare, Key Facts 2
Laboratorios SALVAT SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Laboratorios SALVAT SA, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Laboratorios SALVAT SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Laboratorios SALVAT SA, Deals By Therapy Area, 2012 to YTD 2018 8
Laboratorios SALVAT SA, Medical Devices Deals, 2012 to YTD 2018 9
Laboratorios SALVAT SA, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
iCo Therapeutics Enters into Licensing Agreement with Laboratorios SALVAT 11
Laboratorios SALVAT Enters into Licensing Agreement with Lee’s Pharma 12
Laboratorios SALVAT Enters into Licensing Agreement with Pediapharm 13
Laboratorios SALVAT Enters Into Licensing Agreement With FAES Farma 14
Loop Therapeutics Spin Off from Laboratorios SALVAT 15
Laboratorios SALVAT SA, Key Competitors 16
Laboratorios SALVAT SA, Key Employees 17
Laboratorios SALVAT SA, Subsidiaries 18

List of Figures
Laboratorios SALVAT SA, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Laboratorios SALVAT SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Laboratorios SALVAT SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Laboratorios SALVAT SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Laboratorios SALVAT SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Laboratorios SALVAT SA, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Laboratorios SALVAT SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Laboratorios SALVAT SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Laboratorios SALVAT SA, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Laboratorios SALVAT SA:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • National Bank Of Kuwait Sak
    National Bank Of Kuwait Sak - Strategy, SWOT and Corporate Finance Report Summary National Bank Of Kuwait Sak - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Nuance Communications, Inc. (NUAN)-医療機器分野:企業M&A・提携分析
    Summary Nuance Communications, Inc. (Nuance) is a provider of speech and imaging solutions. It offers solutions such as automated speech recognition, dialog management, capabilities for natural language understanding, optical character recognition (OCR), domain knowledge and implementation capabilit …
  • Air Liquide SA (AI):医療機器:M&Aディール及び事業提携情報
    Summary Air Liquide SA (Air Liquide) is a provider of gases, technologies and services for industrial and health care sectors. The company produces core air gases such as oxygen, nitrogen, and hydrogen along with argon and other rare gases. It supplies gases to customers in industries, including ste …
  • Flotek Industries Inc (FTK):企業の財務・戦略的SWOT分析
    Summary Flotek Industries Inc (Flotek) is a developer of chemistry based technology solutions for energy, industrial and consumer applications. The company offers stimulation chemistry, cementing chemistry, improved oil recovery chemistry, drilling fluid additives, and coil tubing chemistry. Its sti …
  • Abano Healthcare Group Ltd (ABA)-製薬・医療分野:企業M&A・提携分析
    Summary Abano Healthcare Group Ltd (Abano Healthcare), formerly ElderCare New Zealand Ltd is a healthcare service provider that offers Dental, Audiology, Radiology and medical services. The company also operates business in community pathology and radiology sector. It operates businesses in sectors …
  • Electromagnetic Geoservices ASA (EMGS):企業の財務・戦略的SWOT分析
    Summary Electromagnetic Geoservices ASA (EMGS) is an oil and gas service provider that explores workflow working with seismic, petrophysical and geologic data. The company gathers controlled source electromagnetic data and conduct modeling, integration, interpretation. Its technology finds applicati …
  • Zotefoams plc (ZTF):企業の財務・戦略的SWOT分析
    Summary Zotefoams plc (Zotefoams) is a chemical manufacturer that markets cross-linked block foams. The company offers products such as microzote, zotek F, zotek N, T tubes, plastazote, evazote, zotek peba foam, supazote, and others. It offers services such as manufacturing and distribution services …
  • Range Resources Ltd (RRS):石油・ガス:M&Aディール及び事業提携情報
    Summary Range Resources Ltd (Range Resources) is an independent upstream oil and gas company. It explores, develops and produces oil and gas in Georgia, Guatemala and Trinidad. The company works on both onshore and offshore production and its onshore projects are operational through water injection. …
  • Menarini Asia-Pacific Holdings Pte Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary A. Menarini Asia-Pacific Holdings Pte Ltd (A. Menarini Asia-Pacific), formerly Invida Group Pte Ltd, a subsidiary of A. Menarini Industrie Farmaceutiche Riunite Srl is a biopharmaceutical company that develops consumer health care products. The company operates through its divisions includin …
  • Thermo Fisher Scientific Inc (TMO)-医療機器分野:企業M&A・提携分析
    Summary Thermo Fisher Scientific Inc (Thermo Fisher) is a provider of equipment, analytical instruments, reagents and consumables, software and services for research, manufacturing, analysis, discovery and diagnostics. It also delivers a broad selection of analytical instruments, equipment, consumab …
  • Enable Injections Inc:医療機器:M&Aディール及び事業提携情報
    Summary Enable Injections Inc (Enable Injections) is a medical device company that manufactures and develops disposable body-worn bolus injector to deliver high viscosity payloads to the subcutaneous tissue. The company develops delivery device, delivery systems, and injector systems including vial …
  • Samsung Electro-Mechanics Co Ltd (009150):企業の財務・戦略的SWOT分析
    Samsung Electro-Mechanics Co Ltd (009150) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strength …
  • EDF Renewable Energy Inc-エネルギー分野:企業M&A・提携分析
    Summary EDF Renewable Energy, Inc. (EDF Renewable Energy), formerly, enXco, Inc., is an integrated energy company. The company designs, develops, constructs and operates renewable energy projects in the biogas, biomass, hydro, solar, wind and marine energy sectors; and provides storage solutions. It …
  • Swissport Tanzania Limited
    Swissport Tanzania Limited - Strategy, SWOT and Corporate Finance Report Summary Swissport Tanzania Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Welltower Inc:企業の戦略・SWOT・財務情報
    Welltower Inc - Strategy, SWOT and Corporate Finance Report Summary Welltower Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Toma Biosciences Inc-製薬・医療分野:企業M&A・提携分析
    Summary Toma Biosciences Inc (Toma Biosciences) is a biotechnology company that provides genome sequencing solutions. The company launched TOMA OS-Seq cancer assay to laboratories and researchers for the changes in tumors. Its products include reagent kits developed to detect genomic changes in canc …
  • Halozyme Therapeutics Inc (HALO):企業の財務・戦略的SWOT分析
    Halozyme Therapeutics Inc (HALO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Abbott Molecular Inc:医療機器:M&Aディール及び事業提携情報
    Summary Abbott Molecular Inc (Abbott Molecular), formerly Vysis Inc, a subsidiary of Abbott Laboratories, is a medical diagnostics company that provides molecular testing solutions. The company offers infectious disease products, oncology products, genetics products, automation products, molecular d …
  • Revalesio Corp:製薬・医療:M&Aディール及び事業提携情報
    Summary Revalesio Corp (Revalesio) is a developer of novel therapeutics for the treatment of inflammatory diseases. The company conducts research and development activities to develop therapeutics in the areas of respiratory, neuroscience and cardiovascular. Its product pipeline includes drugs targe …
  • National Gypsum Co:企業の戦略・SWOT・財務情報
    National Gypsum Co - Strategy, SWOT and Corporate Finance Report Summary National Gypsum Co - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆